Lung Cancer Market (by Type: SCLC, NSCLC; by Treatment: Surgery, Chemotherapy, Radiotherapy, Photodynamic Therapy (PDT), Laser Therapy; by End-User: Hospitals & Clinics, Cancer Research Centers, Laboratories) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Lung Cancer

1.1. Definition and Scope 

1.1.1. Definition of Lung Cancer

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Lung Cancer Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Lung Cancer Market By Type

1.2.3. Lung Cancer Market By Treatment

1.2.4. Lung Cancer Market By End-User

1.2.5. Lung Cancer Market by Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Lung Cancer Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Lung Cancer Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2019

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019

4.2. R&D Status and Application Source of Lung Cancer Major Manufacturers in 2019

CHAPTER 5. Lung Cancer Market By Type

5.1. Introduction

5.2. Lung Cancer Revenue By Type

5.2.1. Lung Cancer Revenue (US$ Mn) and Forecast, By Type, 2016-2027

5.2.2. SCLC

5.2.2.1. SCLC Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.3. NSCLC

5.2.3.1. NSCLC Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Lung Cancer Market Revenue By Treatment

6.1. Introduction

6.2. Lung Cancer Revenue (US$ Mn) By Treatment

6.2.1. Lung Cancer Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

6.2.2. Surgery

6.2.2.1. Surgery Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.3. Chemotherapy

6.2.3.1. Chemotherapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.4. Radiotherapy

6.2.4.1. Radiotherapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.5. Photodynamic Therapy (PDT)

6.2.5.1. Photodynamic Therapy (PDT) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.6. Laser Therapy

6.2.6.1. Laser Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Lung Cancer Market By End-User 

7.1. Introduction

7.2. Lung Cancer Revenue (US$ Mn) By End-User

7.2.1. Lung Cancer Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

7.2.2. Hospitals & Clinics

7.2.2.1. Hospitals & Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

7.2.3. Cancer Research Centers

7.2.3.1. Cancer Research Centers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

7.2.4. Laboratories

7.2.4.1. Laboratories Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. North America Lung Cancer Market By Country 

8.1. North America Lung Cancer Overview

8.2. U.S.

8.2.1. U.S. Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

8.2.2. U.S. Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027

8.2.3. U.S. Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

8.3. Canada

8.3.1. Canada Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

8.3.2. Canada Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027

8.3.3. Canada Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

8.4. North America PEST Analysis

CHAPTER 9. Europe Lung Cancer Market By Country

9.1. Europe Lung Cancer Market Overview

9.2. U.K.

9.2.1. U.K. Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.2.2. U.K. Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027

9.2.3. U.K. Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.3. Germany

9.3.1. Germany Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.3.2. Germany Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027

9.3.3. Germany Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.4. France 

9.4.1. France Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.4.2. France Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027

9.4.3. France Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.5. Spain

9.5.1. Spain Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.5.2. Spain Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027

9.5.3. Spain Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.6. Rest of Europe

9.6.1. Rest of Europe Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.6.2. Rest of Europe Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027

9.6.3. Rest of Europe Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Lung Cancer Market By Country

10.1. Asia Pacific Lung Cancer Market Overview

10.2. China

10.2.1. China Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.2.2. China Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

10.2.3. China Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.3. Japan

10.3.1. Japan Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.3.2. Japan Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

10.3.3. Japan Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.4. India

10.4.1. India Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.4.2. India Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

10.4.3. India Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.5. Australia

10.5.1. Australia Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.5.2. Australia Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

10.5.3. Australia Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.6. South Korea

10.6.1. South Korea Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.6.2. South Korea Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

10.6.3. South Korea Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.7.2. Rest of Asia-Pacific Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

10.7.3. Rest of Asia-Pacific Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Lung Cancer Market By Country

11.1. Latin America Lung Cancer Market Overview

11.2. Brazil

11.2.1. Brazil Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

11.2.2. Brazil Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

11.2.3. Brazil Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

11.3. Mexico

11.3.1. Mexico Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

11.3.2. Mexico Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

11.3.3. Mexico Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

11.4. Rest of Latin America

11.4.1. Rest of Latin America Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

11.4.2. Rest of Latin America Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 – 2027

11.4.3. Rest of Latin America Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 – 2027

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Lung Cancer Market By Country 

12.1. Middle East & Africa Lung Cancer Market Overview

12.2. Saudi Arabia

12.2.1. Saudi Arabia Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

12.2.2. Saudi Arabia Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

12.2.3. Saudi Arabia Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

12.3. UAE

12.3.1. UAE Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

12.3.2. UAE Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

12.3.3. UAE Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Lung Cancer Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

12.4.2. Rest of Middle East & Africa Lung Cancer Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027

12.4.3. Rest of Middle East & Africa Lung Cancer Market Revenue (US$ Mn) and Forecast By End-User, 2016 – 2027

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Lung Cancer

13.1. Lung Cancer Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Lung Cancer Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. COMPANY PROFILE

14.1. F. Hoffmann-La Roche AG

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (US$ Mn), 2019

14.1.3.2. F. Hoffmann-La Roche AG 2019 Lung Cancer Business Regional Distribution

14.1.4. Product/ Service and Specification

14.1.5. Recent Developments & Business Strategy

14.1.6. Manufacturing Plant Footprint Analysis

14.2. AstraZeneca plc

14.3. Eli Lilly and Company

14.4. The Merck Group

14.5. Sanofi S.A.

14.6. Pfizer Inc.

14.7. GlaxoSmithKline

14.8. Boehringer Ingelheim GmbH

14.9. Others

Cart Summary